| ■ 영문 제목 : Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MA022
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 1월
■ 페이지수 : 150
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 바이오
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)는 세계의 엑소좀 시장 규모가 2023년부터 2030년 사이에 연평균 37.75% 성장하여, 2030년에는 10.3억 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 엑소좀 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 제품별 (키트 및 시약, 기기, 서비스) 분석, 워크 플로우별 (분리 방법, 다운스트림 분석) 분석, 용도별 (암, 신경 퇴행성 질환, 심혈관 질환, 감염증, 기타) 분석, 최종 용도별 (의약품 및 바이오테크놀로지 기업, 병원 및 진단 센터, 학술 및 연구 기관) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동/아프리카) 분석, 경쟁 현황 등의 내용을 게재하고 있습니다. 덧붙여 본 자료는 Danaher Corporation, Hologic Inc., Fujifilm Holdings Corporation, Lonza, Miltenyi Biotec, Bio -Techne Corporation, Qiagen, Thermo Fisher Scientific, Inc, Abcam Plc, Roosterbio, Inc. 와 같은 주요 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 엑소좀 시장 규모 : 제품별
- 엑소좀 키트 및 시약의 시장 규모
- 엑소좀 기기의 시장 규모
- 엑소좀 서비스의 시장 규모
・세계의 엑소좀 시장 규모 : 워크 플로우별
- 분리 방법의 시장 규모
- 다운스트림 분석의 시장 규모
・세계의 엑소좀 시장 규모 : 용도별
- 암에 사용되는 엑소좀의 시장 규모
- 신경 퇴행성 질환에 사용되는 엑소좀의 시장 규모
- 심혈관 질환에 사용되는 엑소좀의 시장 규모
- 감염에 사용되는 엑소좀의 시장 규모
- 기타 용도에 사용되는 엑소좀의 시장 규모
・세계의 엑소좀 시장 규모 : 최종 용도별
- 의약품 및 바이오테크놀로지 기업에서 사용되는 엑소좀의 시장 규모
- 병원 및 진단 센터에서 사용되는 엑소좀의 시장 규모
- 학술 및 연구 기관에서 사용되는 엑소좀의 시장 규모
・세계의 엑소좀 시장 규모 : 지역별
- 북미의 엑소좀 시장 규모
- 유럽의 엑소좀 시장 규모
- 아시아 태평양의 엑소좀 시장 규모
- 중남미의 엑소좀 시장 규모
- 중동/아프리카의 엑소좀 시장 규모
・경쟁 현황
・기업 정보 |
■ 보고서 개요Exosomes Market Growth & Trends
The global exosomes market size is projected to reach USD 1.03 billion by 2030, registering a CAGR of 37.75% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).
Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.
Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.
Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company’s leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.
Exosomes Market Report Highlights
• The kits & reagents segment held the largest revenue share in 2022. Isolation of extracellular vesicles can be difficult, non-specific, and a tedious process. Hence, key players are launching innovative kits and reagents to broaden the applications of exosomes, which is fueling the segment growth
• By workflow, the downstream analysis segment accounted for the largest share in 2022. Major players are offering various technologically advanced products for increasing the utility of downstream analyses, which can positively affect the segment growth
• The cancer application segment dominated the market in 2022 due to the broad range of applications of exosomes in cancer diagnosis, prognosis, and treatment
• The pharmaceutical & biotechnology companies end-use led industry in 2022 due to a rise in the R&D activities
• North America was the dominant region in 2022 due to the presence of key players, rising government funding for the detection of new biomarkers, and high incidence of chronic conditions
■ 보고서 목차Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Technological Advancements In Exosomes Isolation And Analytical Procedures
3.2.1.2 Advanced Applications Of Exosomes
3.2.1.3 Growth In Government And Non-Government Initiatives For Exosome Research
3.2.1.4 Increasing Prevalence Of Cancer
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent Regulations Pertaining To Approval
3.2.2.1 Challenges Associated With Implementation Of Exosome-Based Therapies
3.3 Penetration & Growth Prospect Mapping
3.4 Exosomes Market – Porter’s Analysis
3.5 Exosomes Market – Swot Analysis
3.6 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1 Exosomes Market-Product Movement Analysis
4.2 Kits & Reagents
4.2.1 Global Kits & Reagents Market, 2018 – 2030 (USD Million)
4.3 Instruments
4.3.1 Global Instruments Market, 2018 – 2030 (USD Million)
4.4 Services
4.4.1 Global Services Market, 2018 – 2030 (USD Million)
Chapter 5 Workflow Business Analysis
5.1 Exosomes Market-Workflow Movement Analysis
5.2 Isolation Methods
5.2.1 Global Isolation Methods Market, 2018 – 2030 (USD Million)
5.2.2 Ultracentrifugation
5.2.2.1 Global Ultracentrifugation Market, 2018 – 2030 (USD Million)
5.2.3 Immunocapture On Beads
5.2.3.1 Global Immunocapture On Beads Market, 2018 – 2030 (USD Million)
5.2.4 Precipitation
5.2.4.1 Global Precipitation Market, 2018 – 2030 (USD Million)
5.2.5 Filtration
5.2.5.1 Global Filtration Market, 2018 – 2030 (USD Million)
5.2.6 Others
5.2.6.1 Global Other Isolation Methods Market, 2018 – 2030 (USD Million)
5.3 Downstream Analysis
5.3.1 Global Downstream Analysis Market, 2018 – 2030 (USD Million)
5.3.2 Cell Surface Marker Analysis Using Flow Cytometry
5.3.2.1 Global Cell Surface Marker Analysis Using Flow Cytometry Market, 2018 – 2030 (USD Million)
5.3.3 Protein Analysis Using Blotting & Elisa
5.3.3.1 Global Protein Analysis Using Blotting & Elisa Market, 2018 – 2030 (USD Million)
5.3.4 Rna Analysis With Ngs & Pcr
5.3.4.1 Global Rna Analysis With Ngs & Pcr Market, 2018 – 2030 (USD Million)
5.3.5 Proteomic Analysis Using Mass Spectrometry
5.3.5.1 Global Proteomic Analysis Using Mass Spectrometry Market, 2018 – 2030 (USD Million)
5.3.6 Others
5.3.6.1 Global Other Downstream Analysis Market, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Exosomes Market-Application Movement Analysis
6.2 Cancer
6.2.1 Global Cancer Market, 2018 – 2030 (USD Million)
6.3 Nurodegenrative Diseases
6.3.1 Global Nurodegenerative Diseases Market, 2018 – 2030 (USD Million)
6.4 Cardiovascular Diseases
6.4.1 Global Cardiovascular Diseases Market, 2018 – 2030 (USD Million)
6.5 Infectious Diseases
6.5.1 Global Infectious Diseases Market, 2018 – 2030 (USD Million)
6.6 Others
6.6.1 Global Other Applications Market, 2018 – 2030 (USD Million)
Chapter 7 End-Use Business Analysis
7.1 Exosomes Market-End-Use Movement Analysis
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
7.3 Hospitals & Diagnostics Centers
7.3.1 Global Hospitals & Diagnostics Centers Market, 2018 – 2030 (USD Million)
7.4 Academic & Research Institutes
7.4.1 Global Academic & Research Institutes Market, 2018 – 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Exosomes Market: Regional Movement Analysis
8.2 North America
8.2.1 Swot Analysis
8.2.1.1 North America Exosome Market, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 U.S. Exosome Market, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Canada Exosome Market, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Swot Analysis
8.3.1.1 Europe Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 U.K. Exosome Market, 2018 – 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Germany Exosome Market, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 France Exosome Market, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Italy Exosome Market, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Spain Exosome Market, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Denmark Exosome Market, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Sweden Exosome Market, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Norway Exosome Market, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Swot Analysis
8.4.1.1 Asia Pacific Vacuum Blood Collection Tube, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Japan Exosome Market, 2018 – 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 China Exosome Market, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 India Exosome Market, 2018 – 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Australia Exosome Market, 2018 – 2030 (USD Million)
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Thailand Exosome Market, 2018 – 2030 (USD Million)
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 South Korea Exosome Market, 2018 – 2030 (USD Million)
8.4.8 Singapore
8.4.8.1 Key Country Dynamics
8.4.8.2 Competitive Scenario
8.4.8.3 Singapore Exosome Market, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Swot Analysis
8.5.1.1 Latin America Exosome Market, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Brazil Exosome Market, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Mexico Exosome Market, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Argentina Exosome Market, 2018 – 2030 (USD Million)
8.6 Middle East & Africa (Mea)
8.6.1 Swot Analysis
8.6.1.1 Mea Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 South Africa Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Saudi Arabia Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.4 Uae
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Uae Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Kuwait Exosome Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s Overview
9.1.1 Danaher Corporation
9.1.2 Hologic Inc.
9.1.3 Fujifilm Holdings Corporation
9.1.4 Lonza
9.1.5 Miltenyi Biotec
9.1.6 Bio-Techne Corporation
9.1.7 Qiagen
9.1.8 Thermo Fisher Scientific, Inc
9.1.9 Abcam Plc
9.1.10 Roosterbio, Inc.
9.2 Financial Performance
9.3 Participant Categorization
9.3.1 Market Leaders
9.3.1.1 Exosomes Market Share Analysis, 2022
9.3.2 Strategy Mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/Service Launch
9.3.2.5 Partnerships
9.3.2.6 Others
|
| ※본 조사보고서 [세계의 엑소좀 시장 (2023~2030) : 키트 및 시약, 서비스] (코드 : GRV23MA022) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 엑소좀 시장 (2023~2030) : 키트 및 시약, 서비스] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
